Clinical Utility of Including Circulating Tumor DNA (ctDNA) Monitoring in Standard-of-Care (SOC) Colorectal Cancer (CRC) Surveillance

Experts discuss how multidisciplinary care, pathology review, surgical quality, and circulating tumor DNA (ctDNA) testing together personalize colorectal cancer surveillance and treatment, improving early detection, guiding therapy decisions, reducing patient anxiety, and enhancing long-term outcomes across diverse clinical settings.